The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-Methyl-2-(2-Hydroxyethyl)-7-(3-methylbutoxy)-9-(3-methylbutyl)-beta-carbolin-2-ium bromide ID: ALA2164699
PubChem CID: 54767367
Max Phase: Preclinical
Molecular Formula: C24H35BrN2O2
Molecular Weight: 383.56
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c2c(cc[n+]1CCO)c1ccc(OCCC(C)C)cc1n2CCC(C)C.[Br-]
Standard InChI: InChI=1S/C24H35N2O2.BrH/c1-17(2)8-12-26-23-16-20(28-15-10-18(3)4)6-7-21(23)22-9-11-25(13-14-27)19(5)24(22)26;/h6-7,9,11,16-18,27H,8,10,12-15H2,1-5H3;1H/q+1;/p-1
Standard InChI Key: WQWPESUTDGGMLK-UHFFFAOYSA-M
Molfile:
RDKit 2D
29 30 0 0 0 0 0 0 0 0999 V2000
9.5195 -6.7761 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
5.1068 -7.9249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1056 -8.7522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8205 -9.1651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8187 -7.5121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5340 -7.9212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5343 -8.7476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3213 -9.0018 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3199 -7.6656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8041 -8.3321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6214 -8.2452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9555 -7.4926 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.4663 -6.8258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6508 -6.9160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3909 -9.1641 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.1071 -8.9121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6767 -8.7511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7802 -7.4709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7136 -9.7276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2813 -10.4302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2114 -8.1742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6774 -7.9261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9633 -7.5130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9639 -6.6880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2484 -7.9250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4566 -10.4071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0242 -11.1097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0643 -9.6814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0360 -8.1525 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 7 2 0
6 5 2 0
5 2 1 0
6 7 1 0
7 8 1 0
8 10 1 0
9 6 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
3 15 1 0
11 16 1 0
15 17 1 0
12 18 1 0
8 19 1 0
19 20 1 0
18 21 1 0
17 22 1 0
22 23 1 0
23 24 1 0
23 25 1 0
20 26 1 0
26 27 1 0
26 28 1 0
21 29 1 0
M CHG 2 1 -1 12 1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 383.56Molecular Weight (Monoisotopic): 383.2693AlogP: 4.85#Rotatable Bonds: 9Polar Surface Area: 38.27Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 0.19CX LogD: 0.19Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.54Np Likeness Score: 0.11
References 1. Frédérick R, Bruyère C, Vancraeynest C, Reniers J, Meinguet C, Pochet L, Backlund A, Masereel B, Kiss R, Wouters J.. (2012) Novel trisubstituted harmine derivatives with original in vitro anticancer activity., 55 (14): [PMID:22770529 ] [10.1021/jm300542e ] 2. Meinguet C, Bruyère C, Frédérick R, Mathieu V, Vancraeynest C, Pochet L, Laloy J, Mortier J, Wolber G, Kiss R, Masereel B, Wouters J.. (2015) 3D-QSAR, design, synthesis and characterization of trisubstituted harmine derivatives with in vitro antiproliferative properties., 94 [PMID:25747498 ] [10.1016/j.ejmech.2015.02.044 ]